# A Study to Compare Bioavailability of Naloxone Nasal Spray, Naloxone Hydrochloride (HCl) Intravenous (IV) and Intramuscular Injection (IM) in Healthy Volunteers

> **NCT03827642** · PHASE1 · COMPLETED · sponsor: **INSYS Therapeutics Inc** · enrollment: 24 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** Treatment A: Naloxone Nasal Spray
- **DRUG:** Treatment B: Naloxone Nasal Spray
- **DRUG:** Treatment C: Naloxone HCl Intravenous (IV) Injection
- **DRUG:** Treatment D: Naloxone HCl Intramuscular (IM) Injection

## Key facts

- **NCT ID:** NCT03827642
- **Lead sponsor:** INSYS Therapeutics Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-23
- **Primary completion:** 2018-05-06
- **Final completion:** 2018-05-06
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2019-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03827642

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03827642, "A Study to Compare Bioavailability of Naloxone Nasal Spray, Naloxone Hydrochloride (HCl) Intravenous (IV) and Intramuscular Injection (IM) in Healthy Volunteers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03827642. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*